Bacterial resistance to antibiotics is increasing and will continue to rise if alternative therapies are not developed. The threat is very real and we may face mortality rates encountered in the pre-antibiotic era due to drug-resistant bacterial infections. AmpliPhi Biosciences is harnessing the power of bacteriophages – viruses that infect and kill only bacteria – to provide alternatives to antibiotics, which will result in better controlled infections, fewer side effects and targeted treatments.

There are few public health issues of potentially greater importance for society than antibiotic resistance. It means we are at increasing risk of developing infections that cannot be treated – but resistance can be managed.
Dame Sally Davies, Chief Medical Officer for England, 2013.